January 14, 2026 8:56 pm

Tag: ulcerative colitis treatment

$420M Partnership Brings New Hope for Better IBD Treatments

A new $420 million partnership between Genentech and OMass Therapeutics is developing innovative oral IBD treatments using groundbreaking protein research technology. This collaboration represents significant hope for better treatment options that could transform daily life for millions living with Crohn’s disease and ulcerative colitis.

You Missed

Breakthrough in Crohn's Treatment: New Experimental Drug Offers Hope for Remission

Breakthrough in Crohn’s Treatment: New Experimental Drug Offers Hope for Remission

January 11, 2026
Young Adults with IBD Navigate Complex Healthcare Barriers and Financial Strain

Young Adults with IBD Navigate Complex Healthcare Barriers and Financial Strain

January 11, 2026
The Six-Week Journey Back: My IBD Flare Recovery Roadmap

The Six-Week Journey Back: My IBD Flare Recovery Roadmap

January 11, 2026
When My Skin Became the Battlefield: Living with Pyoderma Gangrenosum and Crohn's Disease

When My Skin Became the Battlefield: Living with Pyoderma Gangrenosum and Crohn’s Disease

January 10, 2026